Search Results - Elisabeth Simader

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure by Philipp Opfermann, Elisabeth Simader, Alessia Felli, Michele Bevilacqua, Caroline Holaubek, Martin Dworschak, Mohamed Mouhieddine, Daniel Zimpfer, Jan Hendrik Ankersmit, Barbara Steinlechner

    Published in Journal of Immunology Research (2020-01-01)
    Get full text
    Article


  2. 2

    Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study by Daniel Aletaha, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Stefan Winkler, Selma Tobudic, Thomas Deimel, Thomas Karonitsch, Stephan Blueml, Felix Kartnig, Daniel Mrak, Elisabeth Simader, Gregor Mitter

    Published in BMJ Open (2025-09-01)
    Get full text
    Article


  3. 3

    Pregnancy outcomes in patients with systemic lupus erythematosus compared to a high‐risk tertiary cohort and to standard population from the Austrian birth registry by Klara Rosta, Florian Heinzl, Valerie Kuczwara, Stefanie Schindler, Veronica Falcone, Anja Catic, Marina Riedmann, Hermann Leitner, Elisabeth Simader, Valentin Ritschl, Tanja Stamm, Alexandra Szlatinay, Peter Mandl, Antonia Mazzucato‐Puchner

    Get full text
    Article


  4. 4

    FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot studyResearch in context by Kastriot Kastrati, Thomas S. Nakuz, Oana C. Kulterer, Irina Geßl, Elisabeth Simader, Daniel Mrak, Michael Bonelli, Hans Peter Kiener, Florian Prayer, Helmut Prosch, Daniel Aletaha, Werner Langsteger, Tatjana Traub-Weidinger, Stephan Blüml, Helga Lechner-Radner, Marcus Hacker, Peter Mandl

    Published in EClinicalMedicine (2024-06-01)
    Get full text
    Article


  5. 5

    Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial by Daniel Mrak, Daniela Sieghart, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Göschl, Maximilian Koblischke, Nikolaus Hommer, Angelika Wagner, Margareta Mayer, Lorenz Schubert, Lukas Hartl, Karin Kozbial, Philipp Hofer, Felix Kartnig, Thomas Hummel, Andreas Kerschbaumer, Thomas Deimel, Antonia Puchner, Venugopal Gudipati, Renate Thalhammer, Petra Munda, Keziban Uyanik-Ünal, Andreas Zuckermann, Gottfried Novacek, Thomas Reiberger, Erika Garner-Spitzer, Roman Reindl-Schwaighofer, Renate Kain, Stefan Winkler, Josef S. Smolen, Karin Stiasny, Gottfried F. Fischer, Thomas Perkmann, Helmuth Haslacher, Markus Zeitlinger, Ursula Wiedermann, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

    Published in Nature Communications (2022-09-01)
    Get full text
    Article


Search Tools: